Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma (Q64716132)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma |
clinical trial |
Statements
Sorafenib as Inhibitor of Collateral Tumor Vessel Growth During Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma (HCC)- a Pilot Trial to Evaluate Safety and Biological Response (English)
0 references
September 2008
0 references
October 2010
0 references
22
0 references
18 year
0 references